Showing results (301-310 of 329) with videos related to

Sort By:
Pageof 33
Cancer|July 1, 1985
Aspiration biopsy of the kidney. Simultaneous collection of cytologic and histologic specimensW M Murphy, B R Zambroni, L D Emerson, et al.
JAMA|August 21, 1987
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgeryW U Shipley, G R Prout, A B Einstein, et al.
Quintessence International (Berlin, Germany : 1985)|July 1, 1990
Finite element analysis of fixed prostheses attached to osseointegrated implantsK R Williams, C J Watson, W M Murphy, et al.
The Journal of Urology|July 1, 1976
Cytology in the diagnosis and followup of transitional cell carcinoma of the urothelium: a review with a case seriesR W Lewis, A C Jackson, W M Murphy, et al.
Der Urologe. Ausg. A|April 24, 2001
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]S H Hautmann, G L Schroeder, F Civantos, et al.
The Journal of Urology|August 1, 1995
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancerM F Sarosdy, R W deVere White, M S Soloway, et al.
Cancer|March 1, 1984
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepaB F Issell, G R Prout, M S Soloway, et al.
The Journal of Urology|March 1, 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerD L Lamm, P M van der Meijden, A Morales, et al.
Cancer|May 15, 1987
Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of lifeC A Presant, M S Soloway, S S Klioze, et al.
Cancer|November 15, 1996
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.
Pageof 33